Nonradioactive assay helps diagnose heparin reaction: Rajiv Pruthi, M.B.B.S.
Rajiv Pruthi, M.B.B.S., explains how Mayo Clinic Laboratories’ serotonin release assay achieves high sensitivity and specificity while avoiding the use of radioactive materials. Serotonin release testing is an important tool in the diagnosis of heparin in
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(01:51)
Can you give a brief overview of the assay you developed and how it works?
(06:28)
The serotonin release assay is utilized within five to 14 days of heparin exposure. Is there a subsequent time when this test would be utilized?
(10:28)
How does this assay improve upon previous approaches?
(12:58)
Is there greater specificity and sensitivity with the use of nonradioactive materials?
(13:46)
What interesting findings have we had through the process of developing and validating this assay?